We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
(-1.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-15.76%
Top 10 Holdings %
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$32.2M |
| 2 |
Agilent Technologies
A
|
+$10.1M |
| 3 |
Incyte
INCY
|
+$9.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$9.65M |
| 5 |
ServiceNow
NOW
|
+$9.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$22.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$19.6M |
| 3 |
Capri Holdings
CPRI
|
+$18.6M |
| 4 |
Delta Air Lines
DAL
|
+$17.6M |
| 5 |
Nutanix
NTNX
|
+$17.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.83% |
| 2 | Technology | 24.23% |
| 3 | Consumer Discretionary | 14.95% |
| 4 | Industrials | 7.4% |
| 5 | Financials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mettler-Toledo International
MTD
$26.8B
| $33.9M | 1.92% |
46,900
-18
| -0% | -$11.7K |
|
|
2
Bristol-Myers Squibb
BMY
$127B
| $30.8M | 1.74% |
+645,994
| New | +$32.2M |
|
3
Amazon
AMZN
$2.5T
| $30.6M | 1.73% |
344,060
-20
| -0% | -$1.66K |
|
4
Palo Alto Networks
PANW
$264B
| $30.3M | 1.71% |
748,806
-274,800
| -27% | -$10.2M |
|
5
Boston Scientific
BSX
$65.8B
| $30.2M | 1.71% |
787,300
-37,800
| -5% | -$1.44M |
|
6
Humana
HUM
$46.7B
| $29.3M | 1.66% |
110,101
-7
| -0% | -$2.02K |
|
7
Ionis Pharmaceuticals
IONS
$9.35B
| $27.7M | 1.57% |
341,800
-49,500
| -13% | -$3.19M |
|
|
APC
8
DELISTED
Anadarko Petroleum
APC
| $25.2M | 1.42% |
554,089
+212,889
| +62% | +$9.65M |
|
9
Autodesk
ADSK
$44.3B
| $24.9M | 1.41% |
159,719
-32,204
| -17% | -$4.81M |
|
10
BioMarin Pharmaceuticals
BMRN
$11.5B
| $24.4M | 1.38% |
274,505
-7
| -0% | -$649 |
|
11
Atlassian
TEAM
$22B
| $24.2M | 1.37% |
215,708
-4
| -0% | -$409 |
|
12
Gilead Sciences
GILD
$161B
| $23.5M | 1.33% |
360,740
+68,691
| +24% | +$4.57M |
|
|
CNH
13
CNH Industrial
CNH
$13.8B
| $22.5M | 1.27% |
2,535,303
-174,638
| -6% | -$1.56M |
|
14
American Express
AXP
$223B
| $21.6M | 1.22% |
197,903
-63,597
| -24% | -$6.68M |
|
15
eBay
EBAY
$48.6B
| $21.5M | 1.21% |
578,447
-206,161
| -26% | -$7.15M |
|
16
EOG Resources
EOG
$78B
| $21.5M | 1.21% |
225,627
+91,618
| +68% | +$8.73M |
|
|
ZEN
17
DELISTED
ZENDESK INC
ZEN
| $21.5M | 1.21% |
252,621
-21
| -0% | -$1.54K |
|
18
Herbalife
HLF
$1.23B
| $20.8M | 1.18% |
393,240
-7,060
| -2% | -$405K |
|
19
Mastercard
MA
$477B
| $16.7M | 0.94% |
70,900
-4,200
| -6% | -$904K |
|
20
DexCom
DXCM
$27.6B
| $16.3M | 0.92% |
547,600
-116,400
| -18% | -$4.09M |
|
21
WIX.com
WIX
$2.15B
| $15.8M | 0.89% |
130,402
-67,340
| -34% | -$7.31M |
|
22
Charles River Laboratories
CRL
$10.9B
| $15.4M | 0.87% |
105,700
-9,739
| -8% | -$1.28M |
|
23
American International
AIG
$41.9B
| $14.7M | 0.83% |
342,046
-40,471
| -11% | -$1.73M |
|
|
XLNX
24
DELISTED
Xilinx Inc
XLNX
| $14.7M | 0.83% |
115,700
-3
| -0% | -$337 |
|
25
Zoetis
ZTS
$31.6B
| $13.6M | 0.77% |
135,131
+34,951
| +35% | +$3.17M |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q1 2019 Portfolio in Review
As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.
- PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
- PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
- PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
- PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
- PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
- PDT Partners opened 90 new positions and closed 118 in Q1 2019.
- PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.
Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.